Literature DB >> 24591002

Can we change the past for colorectal cancer patients and how do we move forward?

Justin Y Jeon1, Jeffrey A Meyerhardt.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24591002      PMCID： PMC4013242          DOI： 10.1002/cncr.28567

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  20 in total

Review 1.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 2.  Epigenetic regulation on gene expression induced by physical exercise.

Authors:  J Ntanasis-Stathopoulos; J G Tzanninis; A Philippou; M Koutsilieris
Journal:  J Musculoskelet Neuronal Interact       Date:  2013-06       Impact factor: 2.041

Review 3.  Beyond standard adjuvant therapy for colon cancer: role of nonstandard interventions.

Authors:  Jeffrey A Meyerhardt
Journal:  Semin Oncol       Date:  2011-08       Impact factor: 4.929

4.  Association between physical activity and mortality in colorectal cancer: a meta-analysis of prospective cohort studies.

Authors:  Youjin Je; Justin Y Jeon; Edward L Giovannucci; Jeffrey A Meyerhardt
Journal:  Int J Cancer       Date:  2013-07-10       Impact factor: 7.396

Review 5.  Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.

Authors:  Katherine Esposito; Paolo Chiodini; Annalisa Capuano; Giuseppe Bellastella; Maria Ida Maiorino; Concetta Rafaniello; Demosthenes B Panagiotakos; Dario Giugliano
Journal:  Endocrine       Date:  2013-04-02       Impact factor: 3.633

6.  Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.

Authors:  Teppei Morikawa; Aya Kuchiba; Paul Lochhead; Reiko Nishihara; Mai Yamauchi; Yu Imamura; Xiaoyun Liao; Zhi Rong Qian; Kimmie Ng; Andrew T Chan; Jeffrey A Meyerhardt; Edward Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Cancer Res       Date:  2013-02-26       Impact factor: 12.701

7.  Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients.

Authors:  James B Rawson; Zhouyu Sun; Elizabeth Dicks; Darshana Daftary; Patrick S Parfrey; Roger C Green; Steven Gallinger; John R McLaughlin; Peizhong P Wang; Julia A Knight; Bharati Bapat
Journal:  Nutr Cancer       Date:  2012-09-11       Impact factor: 2.900

8.  Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.

Authors:  Mikkael A Sekeres; Ramon V Tiu; Rami Komrokji; Jeffrey Lancet; Anjali S Advani; Manuel Afable; Ricki Englehaupt; Joyce Juersivich; David Cuthbertson; Jennifer Paleveda; Ali Tabarroki; Valeria Visconte; Hideki Makishima; Andres Jerez; Ronald Paquette; Alan F List; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

9.  Metabolic dysregulation of the insulin-glucose axis and risk of obesity-related cancers in the Framingham heart study-offspring cohort (1971-2008).

Authors:  Niyati Parekh; Yong Lin; Maya Vadiveloo; Richard B Hayes; Grace L Lu-Yao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-24       Impact factor: 4.254

10.  A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue.

Authors:  Tina Rönn; Petr Volkov; Cajsa Davegårdh; Tasnim Dayeh; Elin Hall; Anders H Olsson; Emma Nilsson; Asa Tornberg; Marloes Dekker Nitert; Karl-Fredrik Eriksson; Helena A Jones; Leif Groop; Charlotte Ling
Journal:  PLoS Genet       Date:  2013-06-27       Impact factor: 5.917
View more
  1 in total

1.  Downregulated Tim-3 expression is responsible for the incidence and development of colorectal cancer.

Authors:  Ping Zhang; Yan Wang; Xue-Rong Liu; Shi-Ru Hong; Jian Yao
Journal:  Oncol Lett       Date:  2018-05-11       Impact factor: 2.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.